128 related articles for article (PubMed ID: 25736461)
1. A contemporary review of management and prognostic factors of upper tract urothelial carcinoma.
Leow JJ; Orsola A; Chang SL; Bellmunt J
Cancer Treat Rev; 2015 Apr; 41(4):310-9. PubMed ID: 25736461
[TBL] [Abstract][Full Text] [Related]
2. Management of Upper Tract Urothelial Carcinoma in a Double Collecting System Kidney.
Zohar Y; Sivan B; Mintz I; Hefer B; Rouvinov K; Shani Shrem N; Mabjeesh NJ
J Pers Med; 2024 Jan; 14(2):. PubMed ID: 38392591
[TBL] [Abstract][Full Text] [Related]
3. UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma.
Kokorovic A; Matin SF
Ther Adv Med Oncol; 2020; 12():1758835920937950. PubMed ID: 32670424
[TBL] [Abstract][Full Text] [Related]
4. Upper Tract Urothelial Cancer: Guideline of Guidelines.
Pandolfo SD; Cilio S; Aveta A; Wu Z; Cerrato C; Napolitano L; Lasorsa F; Lucarelli G; Verze P; Siracusano S; Quattrone C; Ferro M; Bologna E; Campi R; Del Giudice F; Bertolo R; Amparore D; Palumbo S; Manfredi C; Autorino R
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539450
[TBL] [Abstract][Full Text] [Related]
5. Second-line therapy in advanced upper gastrointestinal cancers: current status and new prospects.
Saletti P; Zaniboni A
J Gastrointest Oncol; 2018 Apr; 9(2):377-389. PubMed ID: 29755778
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of upper tract urothelial carcinoma.
Lucca I; Leow JJ; Shariat SF; Chang SL
Hematol Oncol Clin North Am; 2015 Apr; 29(2):271-88, ix. PubMed ID: 25836934
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy in advanced bladder cancer: what have we learned?
Jordan EJ; Iyer G
Urol Clin North Am; 2015 May; 42(2):253-62, ix. PubMed ID: 25882566
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of bladder cancer.
Malats N; Real FX
Hematol Oncol Clin North Am; 2015 Apr; 29(2):177-89, vii. PubMed ID: 25836927
[TBL] [Abstract][Full Text] [Related]
9. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
[TBL] [Abstract][Full Text] [Related]
11. Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors.
Bellmunt J; Werner L; Leow JJ; Mullane SA; Fay AP; Riester M; Van Hummelen P; Taplin ME; Choueiri TK; Van Allen E; Rosenberg J
PLoS One; 2015; 10(6):e0124711. PubMed ID: 26039708
[TBL] [Abstract][Full Text] [Related]
12. Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer.
Ekin RG; Akarken I; Cakmak O; Tarhan H; Celik O; Ilbey YO; Divrik RT; Zorlu F
Asian Pac J Cancer Prev; 2015; 16(8):3241-5. PubMed ID: 25921126
[TBL] [Abstract][Full Text] [Related]
13. Perioperative therapy for muscle invasive bladder cancer.
Leow JJ; Fay AP; Mullane SA; Bellmunt J
Hematol Oncol Clin North Am; 2015 Apr; 29(2):301-18, ix. PubMed ID: 25836936
[TBL] [Abstract][Full Text] [Related]
14. Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
Decaestecker K; Lumen N; Ringoir A; Oosterlinck W
Urol Int; 2016; 96(1):14-9. PubMed ID: 25791565
[TBL] [Abstract][Full Text] [Related]
15. [Use of chemotherapy and radiotherapy in the treatment of urothelial carcinoma of the upper urinary tract].
Gustin P; Yossi S; Lafont M; Peyraga G; Trémolières P; Rousseau D; Cellier P; Paumier A; Martin F; Chapet O; Mesgouez-Nebout N
Cancer Radiother; 2015 Apr; 19(2):120-6. PubMed ID: 25770883
[TBL] [Abstract][Full Text] [Related]
16. p53 Status correlates with the risk of recurrence in non-muscle invasive bladder cancers treated with Bacillus Calmette-Guérin: a meta-analysis.
Zhou X; Zhang G; Tian Y
PLoS One; 2015; 10(3):e0119476. PubMed ID: 25742650
[TBL] [Abstract][Full Text] [Related]
17. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
[TBL] [Abstract][Full Text] [Related]
18. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Systemic Inflammation Score Predicts the Prognosis of Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
Wang Q; Ye J; Chen Z; Liao X; Wang X; Zhang C; Zheng L; Han P; Wei Q; Bao Y
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
